DCM Shriram Fine Chemicals appoints Anil Kumar Khaitan as independent director

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Anil Kumar Khaitan appointed as non-executive independent director
  • Five-year term effective September 4, 2026, subject to shareholder approval
  • Brings 48 years of experience across pharma, steel, and jute sectors
  • Appointment approved by Board on September 3, 2026
powered bylight_fuzz_icon
49978828

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Ltd has appointed Anil Kumar Khaitan as an additional non-executive independent director. The appointment is effective September 4, 2026, and is subject to shareholder approval.

The Board of Directors approved the induction during its meeting held on September 3, 2026. The decision was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Appointment Details

Mr. Khaitan will serve a term of five consecutive years, from September 4, 2026, to September 3, 2031. The Nomination and Remuneration Committee recommended his appointment to the Board.

Particulars Details
Name Anil Kumar Khaitan
DIN 00759951
Category Non-Executive Independent Director
Term Start September 4, 2026
Term End September 3, 2031

Profile and Experience

Mr. Khaitan, aged 70, is the Chairman of SNK Corp. He holds a B.Com degree and an MBA from IMI, Geneva (1981). He joined his family business in 1976.

He brings 48 years of diversified business experience across the jute, paper, pharmaceutical, copper, and steel industries, including international operations. His expertise includes strategic business planning, financial management, and human resource development.

Mr. Khaitan is a past President of PHD CCI and has served on the executive committees of FICCI and ASSOCHAM. He is also Chairman of the Governing Board of the ICSI Registered Valuers Organization.

Regulatory Compliance

The company confirmed that none of the existing directors are related to Mr. Khaitan. He is not debarred from holding office under any SEBI order or authority directive.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.87%+0.65%+4.58%-9.67%0.0%0.0%

How might Mr. Khaitan's extensive experience in pharmaceuticals and steel influence DCM Shriram's strategic diversification or supply chain resilience?

What specific governance reforms or board committee assignments are anticipated for Mr. Khaitan given his background in valuation and industry leadership?

Could this appointment signal an upcoming shift in DCM Shriram's capital allocation strategy or M&A activities under new board oversight?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like18
dislike

DCM Shriram Fine Chemicals promoter Urvashi Tilakdhar raises stake to 30.94%

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Promoter Urvashi Tilakdhar acquired 30,53,531 shares (3.52%) via off-market transfer on August 24, 2026
  • Shares were transferred from immediate relatives Akshay Dhar and Aditi Dhar as a gift out of love and affection
  • Tilakdhar's individual holding rises from 27.42% to 30.94%
  • Total promoter group holding remains unchanged at 50.11%
  • Disclosure filed under Regulation 10(6) of SEBI SAST Regulations on August 28, 2026
powered bylight_fuzz_icon
49345973

*this image is generated using AI for illustrative purposes only.

Promoter Urvashi Tilakdhar acquired 30,53,531 equity shares of DCM Shriram Fine Chemicals Ltd , representing a 3.52% stake, through an off-market transfer on August 24, 2026.

The acquisition was executed via inter-se transfers from immediate relatives Akshay Dhar and Aditi Dhar as a gift out of love and affection. The move increases Tilakdhar’s total holding in the company from 27.42% to 30.94%.

Shareholding Structure Changes

The shares were transferred without any change in the total promoter group holding, which remains at 50.11% (4,35,90,115 shares). The transaction consolidates individual promoter holdings within the group.

Entity Pre-Acquisition Holding Shares Transferred Post-Acquisition Holding
Urvashi Tilakdhar 2,38,52,675 (27.42%) +30,53,531 2,69,06,206 (30.94%)
Akshay Dhar 15,26,766 (1.76%) -15,26,766 --
Aditi Dhar 15,26,765 (1.76%) -15,26,765 --

Regulatory Disclosure

The company submitted the disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, to both BSE and NSE on August 28, 2026. The acquirer relied on the exemption provided under Regulation 10(1)(a)(i). Prior disclosure regarding the proposed acquisition was made on August 17, 2026, in compliance with Regulation 10(5).

The total equity share capital of the company remains unchanged at 8,69,92,185 shares.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.87%+0.65%+4.58%-9.67%0.0%0.0%

How might the consolidation of promoter holdings under Urvashi Tilakdhar influence corporate governance and decision-making agility at DCM Shriram Fine Chemicals?

Will this increased individual stake by the promoter signal potential future buybacks or dividend policy adjustments to reward shareholders?

Does the reliance on SEBI Regulation 10(1)(a)(i) exemption set a precedent for how related-party transactions will be structured in future capital maneuvers?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like20
dislike

More News on DCM Shriram Fine Chemicals

1 Year Returns:0.00%